Compare CZFS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZFS | PROF |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 270.7M |
| IPO Year | 1995 | 2017 |
| Metric | CZFS | PROF |
|---|---|---|
| Price | $62.00 | $6.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 6.6K | ★ 357.8K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.15% | N/A |
| EPS Growth | ★ 30.26 | 25.89 |
| EPS | ★ 7.62 | 1.41 |
| Revenue | $9,881,000.00 | ★ $16,098,000.00 |
| Revenue This Year | N/A | $115.41 |
| Revenue Next Year | $2.64 | $60.63 |
| P/E Ratio | $8.32 | ★ $4.56 |
| Revenue Growth | 2.82 | ★ 50.73 |
| 52 Week Low | $49.99 | $3.90 |
| 52 Week High | $69.30 | $8.95 |
| Indicator | CZFS | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 53.73 |
| Support Level | $58.03 | $5.75 |
| Resistance Level | $63.59 | $7.08 |
| Average True Range (ATR) | 2.24 | 0.45 |
| MACD | 0.42 | 0.17 |
| Stochastic Oscillator | 92.13 | 83.43 |
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.